Spring Bank Pharmaceuticals, Inc. — Form D

Spring Bank Pharmaceuticals, Inc. of HOPKINTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-25. The offering totals $8.0M, of which $4.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Jonathon Ellsworth BatesDirectorMilford, MA
Martin DriscollDirectorSouthlake, TX
Martin DriscollExecutive OfficerSouthlake, TX
Jonathan Kris BatesDirectorHopkinton, MA
R.P. Kris IyerDirectorHopkinton, MA
David Kris ArkowitzDirectorHopkinton, MA
Nezam AfdhalExecutive OfficerHopkinton, MA
Jonathan FreveExecutive OfficerHopkinton, MA
David Ellsworth ArkowitzDirectorMilford, MA
Radhakrishnan Parameswaran IyerDirectorMilford, MA
Radhakrishnan Parameswaran IyerExecutive OfficerMilford, MA
Jonathan Ellsworth BatesDirectorMilford, MA
Guy Parameswaran MacdonaldDirectorMilford, MA
Douglas John JensenDirectorMilford, MA
Douglas John JensenExecutive OfficerMilford, MA
Michael Francis CroninExecutive OfficerMilford, MA
Guy Francis MacdonaldDirectorMilford, MA
Donald Moore MitchellExecutive OfficerMilford, MA
Nezam Ellsworth AfdhalExecutive OfficerMilford, MA
Gregg Ellsworth BeloffExecutive OfficerMilford, MA
Kurt M EichlerDirectorMarietta, GA

Other filings by this issuer (4)

FiledFormOfferingSold
2016-11-23D$15.0M$15.0M
2015-02-27D/A$21.6M$21.6M
2015-01-14D$15.0M$11.6M
2014-02-03D$6.3M$6.3M

More